bupropion and vortioxetine

bupropion has been researched along with vortioxetine in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Buchbjerg, JK; Chen, G; Højer, AM; Lee, R; Serenko, M; Zhao, Z1
Aalto-Setälä, M; Brignone, M; Campbell, R; Cure, S; Danchenko, N; Diamand, F; Hallinen, T; Kolasa, K; Koponen, H; Soini, E1
Chen, C; Shan, W1

Reviews

1 review(s) available for bupropion and vortioxetine

ArticleYear
Pharmacological and non-pharmacological treatments for major depressive disorder in adults: A systematic review and network meta-analysis.
    Psychiatry research, 2019, Volume: 281

    Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Bupropion; Cognitive Behavioral Therapy; Depressive Disorder, Major; Fluoxetine; Humans; Mirtazapine; Network Meta-Analysis; Treatment Outcome; Venlafaxine Hydrochloride; Vortioxetine

2019

Trials

1 trial(s) available for bupropion and vortioxetine

ArticleYear
Pharmacokinetic drug interactions involving vortioxetine (Lu AA21004), a multimodal antidepressant.
    Clinical drug investigation, 2013, Volume: 33, Issue:10

    Topics: Adolescent; Adult; Antidepressive Agents; Antifungal Agents; Bupropion; Cohort Studies; Contraceptives, Oral, Hormonal; Cross-Over Studies; Drug Interactions; Enzyme Induction; Enzyme Inhibitors; Female; Fluconazole; Humans; Ketoconazole; Male; Middle Aged; Omeprazole; Piperazines; Rifampin; Single-Blind Method; Sulfides; Vortioxetine; Young Adult

2013

Other Studies

1 other study(ies) available for bupropion and vortioxetine

ArticleYear
Cost-utility analysis of vortioxetine versus agomelatine, bupropion SR, sertraline and venlafaxine XR after treatment switch in major depressive disorder in Finland.
    Expert review of pharmacoeconomics & outcomes research, 2017, Volume: 17, Issue:3

    Topics: Acetamides; Antidepressive Agents; Bupropion; Cost-Benefit Analysis; Decision Trees; Depressive Disorder, Major; Finland; Humans; Markov Chains; Models, Theoretical; Piperazines; Recurrence; Sertraline; Sulfides; Treatment Outcome; Venlafaxine Hydrochloride; Vortioxetine

2017